• About Ajanta
    • Overview
    • Milestones
    • Mission & Philosophy
    • Board Of Directors
    • Composition of Board Committees
    • Awards and Accreditations
  • Operations
    • R&D
    • Manufacturing
    • Quality
  • Our Business
    • Branded Generics
    • Generics
    • Institutions
  • Media
    • News Release
    • Media Library
    • Media Coverage
  • Ajanta Talent
    • Life at Ajanta
      • CLP
      • Work Culture
    • Work with us
  • Investors
    • Financials
      • Analysis
      • Quarterly Results
      • Investor Presentation
      • Annual Reports
      • Others
        • Subsidiary Accounts
        • AGM Presentation
    • Corporate Governance
      • Policies & Codes
      • Corporate Governance Reports
      • Shareholding Pattern
      • Terms of Appointment of
        Independent Directors
      • Directors Familiarisation Programme
      • Memorandum & Articles
        of Association
    • Investor Information
      • Statutory Communications
      • Analyst Coverage
      • Unclaimed Dividend
      • Unclaimed Shares
      • Investor Contact
      • KYC forms
      • FAQs
      • Miscellaneous
  • Contact Us
    • Contact Us
    • Feedback
  • Global Presence
  • Careers
  • Online Payment
Menu
  • About Ajanta

      • About Ajanta

        Established in 1973 and headquartered in Mumbai-India, we are committed to 'Serve Health Care Needs Worldwide'

    • Overview
    • Milestones
    • Mission & Philosophy
    • Board Of Directors
    • Composition of Board
      Committees
    • Awards and Accreditations
  • Operations

      • Operations

        We recognize that 'innovation is the key to success' and have been consistently investing in R&D over the last decade.

    • R&D
    • Manufacturing
    • Quality
  • Our Business

      • Our Business

        Over the years, Ajanta Pharma has established a wide marketing network that is operative in domestic and international markets.

    • Branded Generics
    • Generics
    • Institutions
  • Media

      • Media

        Media has been always very supportive in enhancing company’s brand value. We bring all top updates of the same.

    • News Release
    • Media Library
    • Media Coverage
  • Ajanta Talent

      • Ajanta Talent

        Our success is attributed to the efficient and committed Ajantaites working together towards a common goal.

    • Life at Ajanta
      • CLP
      • Work Culture
    • Work with us
  • Investors

      • Investor

        We value the trust our investors, bankers, institutions and other stakeholders have placed in us.

    • Financials
      • Analysis
      • Quarterly Results
      • Investor Presentation
      • Annual Reports
      • Others
        • Subsidiary Accounts
        • AGM Presentation
    • Corporate Governance
      • Policies & Codes
      • Corporate Governance Reports
      • Shareholding Pattern
      • Terms of Appointment of
        Independent Directors
      • Directors Familiarisation Programme
      • Memorandum & Articles
        of Association
    • Investor Information
      • Statutory Communications
      • Analyst Coverage
      • Unclaimed Dividend
      • Unclaimed Shares
      • Investor Contact
      • KYC forms
      • FAQs
      • Miscellaneous
  • Contact Us

      • Contact Us

        We pride ourselves in building strong relationships, as we believe that thriving relationships will provide us with a distinct competitive

    • Contact Us
    • Feedback

Statutory Communication

 Home Investors Investor Information Statutory Communication

Choose Year

  • 2022-2023
  • 2021-2022
  • 2020-2021
  • 2019-2020
  • 2018-2019


  • Reg47 Postal Ballot Notice
  • Completion of dispatch of Postal Ballot Notice
  • Postal Ballot Notice - Issue of bonus shares
  • Issue of Bonus Shares Postal Ballot
  • Grant of Options and Allotment of Shares
  • Newspaper advertisement for transfer of Equity Shares to IEPF


  • Disclosure of Related Party Transactions HY2 2022
  • Written Transcript on Earnings Call Q4 FY2022
  • Newspaper Publication of the Results Q4 FY 2022
  • Audio Recording of Earnings Call Q4 FY 2022
  • Outcome of Board Meeting Q4FY2022
  • Earnings Conference Call Q4FY2022
  • Intimation of Board Meeting Q4 FY 2022
  • Closure of Trading Window
  • Written Transcript of Earnings Call Q3 FY2022
  • Financial results in newspapers for Board Meeting Q3 2022
  • Audio Recording of Earnings Call Q3FY2022
  • Earnings conference call Q3FY2022
  • Intimation of Board meeting Q3FY2022
  • Outcome of Board Meeting
  • Intimation of Record Date
  • Press Release Buy back 2021
  • Intimation of Buyback of Shares
  • Disclosure of Related Party Transactions HY12022
  • Written Transcript of Earnings Call Q2 FY2022
  • Financial Results in Newspapers for Board Meeting Q22022
  • Audio Recording of Earnings Call Q2FY2022
  • Intimation of Record Date
  • Revised Earnings Conference Call Q2 FY2022
  • Earnings Conference Call Q2 FY2022
  • Intimation of Board Meeting Q2 FY2022
  • Trading Window Closure Q22022
  • Outcome of Earnings Call Q1FY2022
  • Financial Results in Newspapers for Board Meeting Q1 2022
  • Earnings Conference Call Q1 FY2022
  • Intimation of Board Meeting Q1 FY2022
  • Voting Results and Scrutinizers Report of 42nd AGM
  • Trading Window Closure Q12022
  • Newspaper Advertisement as per MCA Circular
  • Newspaper Advertisement as per Rule20
  • Investment in LLP
  • Intimation of Options Granted
  • Intimation of AGM
  • Newspaper Intimation for Transfer of Equity Shares to IEPF(20132014)


  • Disclosure of Related Party Transactions HY22021
  • Written Transcript on Earnings Call Q4FY2021
  • Outcome of Earnings Call Q4FY2021
  • Earnings Conference Call Q4FY2021
  • Financial Results in Newspapers for Board Meeting Q42021
  • Notice in Newspapers for Board Meeting Notice Q4FY2021
  • Intimation of BM Q4 2021
  • Financial Results in Newspapers for Board Meeting Q32021
  • Financial Results in Newspapers for Board Meeting Q22021
  • Financial Results in Newspapers for Board Meeting Q12021
  • Notice in Newspapers for Board Meeting Notice Q3FY2021
  • Notice in Newspapers for Board Meeting Notice Q2FY2021
  • Notice in Newspapers for Board Meeting Notice Q1FY2021
  • Closure of Trading Window Q42021
  • Intimation of BM Q3 2021
  • Closure of Trading Window Q32021
  • Disclosure of Related Party Transactions HY12021
  • Intimation of BMQ2 2021
  • Credit Rating Letter
  • Closure of Trading Window Q22021
  • Voting Results and Scrutinizers report of 41st AGM
  • Intimation of BMQ1 2021
  • Closure of Trading Window Q12021
  • Intimation of BM Q42020
  • Closure of Trading Window Q42020
  • Newspaper advertisement as per MCA circular
  • Newspaper advertisement for updation of shareholder details
  • Notice of book closure and e-voting for 41st AGM
  • Notice of 41st AGM


  • Financial Results in Newspapers for Board Meeting Q42020
  • Financial Results in Newspapers for Board Meeting Q32020
  • Financial Results in Newspapers for Board Meeting Q22020
  • Financial Results in Newspapers for Board Meeting Q12020
  • Notice in Newspapers for Board Meeting Notice Q42020
  • Notice in Newspapers for Board Meeting Notice Q32020
  • Notice in Newspapers for Board Meeting Notice Q22020
  • Notice in Newspapers for Board Meeting Notice Q12020
  • Disclosure of Related Party Transactions HY22020
  • Disclosure of Related Party Transactions HY12020
  • Intimation of BM Q3 2020
  • Closure of Trading Window Q32020
  • Intimation of BM Q2 2020
  • Closure of Trading Window Q2 2020
  • Intimation of BM Q1 2020
  • Closure of Trading Window Q1 2020
  • Voting Results and Scrutinizers report of 40thAGM
  • Closure of Trading Window
  • Intimation of BM Q4 2019
  • Credit Rating Letter
  • Intimation Under Regulation 30 for Grant and Allotment of Shares
  • Intimation Under Regulation 30 for Allotment of Shares
  • Intimation Under Regulation 30 for Resignation of a Director
  • Notice of book closure and e-voting for 40th AGM
  • Notice, Attendance Slip and Proxy form of 40th AGM


  • Financial Results in Newspapers for Board Meeting Q32019
  • Notice in Newspapers for Board Meeting Notice Q3FY2019
  • Disclosure of Related Party Transactions HY22019
  • Intimation of BM Q3 2019 and Trading Window closure
  • Intimation of BM Q2 2019 & Trading Window closure
  • Mandatory dematerialization of physical shares
  • Intimation under regulation 30 of LODR (10092018)
  • Intimation Under Regulation 30 for Resignation of a Director
  • US FDA Inspection of our Dahej Facility in July 2018
  • Intimation of Board Meeting Q1 2019 & Trading Window Closure
  • Intimation of Board Meeting Q4 2018 & Trading Window Closure
  • Voting Results and Scrutinizer's report of 39th AGM
  • Notice of book closure & e-voting for 39th AGM
  • Notice, Attendance Slip and Proxy form of 39th AGM
Archives
Scroll

About Ajanta

  • Overview
  • Milestones
  • Mission & Philosophy
  • Board of Directors
  • Composition of Board
    Committees
  • Awards and Accreditations

Quick Links

  • News
  • Our Business
  • News Release
  • Ajanta Talents
  • Share Price
  • Contact Us

Website Compatible Browsers: IE11, Firefox, Safari, Chrome

© Copyright 2021 | Ajanta Pharma All rights reserved.Disclaimer | Privacy Policy | Safe Harbour | Sitemap

Designed & Developed by
Scroll